Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I/II trial of tremelimumab in patients with metastatic melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I/II trial of tremelimumab in patients with metastatic melanoma.
Phase I/II trial of tremelimumab in patients with metastatic melanoma. J Clin Oncol. 2009 Mar 01; 27(7):1075-81.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Dose-Response Relationship, Drug
Drug-Related Side Effects and Adverse Reactions
Female
Humans
Infusions, Intravenous
Male
Melanoma
Middle Aged
Survival Analysis
authors with profiles
Thomas F. Gajewski